Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
复制标题
DOI:
10.1155/2017/9673537
复制
发表时间:
2017
影响因子:
4.6
通讯作者:
Minond D
中科院分区:
文献类型:
--
作者:
Moss ML;Minond D
Since its discovery, ADAM17, also known as TNFα converting enzyme or TACE, is now known to process over 80 different substrates. Many of these substrates are mediators of cancer and inflammation. The field of ADAM metalloproteinases is at a crossroad with many of the new potential therapeutic agents for ADAM17 advancing into the clinic. Researchers have now developed potential drugs for ADAM17 that are selective and do not have the side effects which were seen in earlier chemical entities that targeted this enzyme. ADAM17 inhibitors have broad therapeutic potential, with properties ranging from tumor immunosurveillance and overcoming drug and radiation resistance in cancer, as treatments for cardiac hypertrophy and inflammatory conditions such as inflammatory bowel disease and rheumatoid arthritis. This review focuses on substrates and inhibitors identified more recently for ADAM17 and their role in cancer and inflammation.
登录
查看更多内容
DOI:
10.1007/978-94-007-7359-2_11
发表时间:
2014-01-01
期刊:
CARBONIC ANHYDRASE: MECHANISM, REGULATION, LINKS TO DISEASE, AND INDUSTRIAL APPLICATIONS
影响因子:
--
作者:
Benej, Martin;Pastorekova, Silvia;Pastorek, Jaromir
通讯作者:
Pastorek, Jaromir
DOI:
10.1073/pnas.1524292113
发表时间:
2016-06-07
影响因子:
11.1
作者:
Cai, Bishuang;Thorp, Edward B.;Tabas, Ira
通讯作者:
Tabas, Ira
影响因子:
5.4
作者:
Bang, Bo Ram;Kim, Sang Jick;Yagita, Hideo;Croft, Michael;Kang, Young Jun
通讯作者:
Kang, Young Jun
DOI:
10.1073/pnas.1307478110
发表时间:
2013-06-11
影响因子:
11.1
作者:
Dang, Michelle;Armbruster, Nicole;Herrlich, Andreas
通讯作者:
Herrlich, Andreas
影响因子:
158.5
作者:
Blaydon, Diana C.;Biancheri, Paolo;Kelsell, David P.
通讯作者:
Kelsell, David P.